1. Home
  2. YMAB vs BOC Comparison

YMAB vs BOC Comparison

Compare YMAB & BOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • BOC
  • Stock Information
  • Founded
  • YMAB 2015
  • BOC 2009
  • Country
  • YMAB United States
  • BOC United States
  • Employees
  • YMAB N/A
  • BOC N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • BOC
  • Sector
  • YMAB Health Care
  • BOC
  • Exchange
  • YMAB Nasdaq
  • BOC Nasdaq
  • Market Cap
  • YMAB 386.7M
  • BOC 431.5M
  • IPO Year
  • YMAB 2018
  • BOC 2017
  • Fundamental
  • Price
  • YMAB $8.61
  • BOC $13.37
  • Analyst Decision
  • YMAB Buy
  • BOC Buy
  • Analyst Count
  • YMAB 10
  • BOC 2
  • Target Price
  • YMAB $13.91
  • BOC $20.00
  • AVG Volume (30 Days)
  • YMAB 874.6K
  • BOC 229.2K
  • Earning Date
  • YMAB 11-07-2025
  • BOC 11-11-2025
  • Dividend Yield
  • YMAB N/A
  • BOC N/A
  • EPS Growth
  • YMAB N/A
  • BOC N/A
  • EPS
  • YMAB N/A
  • BOC 0.02
  • Revenue
  • YMAB $85,385,000.00
  • BOC $111,568,551.00
  • Revenue This Year
  • YMAB N/A
  • BOC $7.79
  • Revenue Next Year
  • YMAB $13.97
  • BOC $1.77
  • P/E Ratio
  • YMAB N/A
  • BOC $646.41
  • Revenue Growth
  • YMAB N/A
  • BOC 9.53
  • 52 Week Low
  • YMAB $3.55
  • BOC $12.27
  • 52 Week High
  • YMAB $16.11
  • BOC $16.20
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 81.21
  • BOC 49.70
  • Support Level
  • YMAB $8.50
  • BOC $13.20
  • Resistance Level
  • YMAB $8.56
  • BOC $13.77
  • Average True Range (ATR)
  • YMAB 0.02
  • BOC 0.29
  • MACD
  • YMAB -0.12
  • BOC 0.01
  • Stochastic Oscillator
  • YMAB 100.00
  • BOC 29.82

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

Share on Social Networks: